Abstract
Two new spliceostatin derivatives, designed as spliceostatin H (1) and spliceostatin I (2), and one known compound FR901464 (3), were isolated from the strain Pseudomonas sp. HS-NF-1408. Their structures were determined by the comprehensive spectroscopic data, including 1D, 2D NMR, MS spectral analysis and comparison with data from the literature. Compound 1 exhibited potent cytotoxicity activity against A549 and HepG2 with IC50 values of 3.57 and 16.72 μg/ml, respectively.
The spliceostatin class of natural products, which has two highly functionalized tetrahydropyran rings linked by a diene chain, was reported to be potent cytotoxic agents via inhibition of the spliceosome, a key–protein complex in the biosynthesis of mature mRNA [1,2,3]. Due to the interesting architecture and biological activity, many natural and synthetic spliceostatin compounds have been described with the aim of discovering more potent drug leads [4,5,6,7,8]. In our ongoing effort to exploit novel bioactive compounds from microbial sources, the strain Pseudomonas sp. HS-NF-1408 obtained from a soil sample was selected for further study because of its cytotoxic activity against A549 and HepG2. As a result, two new members of the spliceostatins group, designed as spliceostatin H (1), spliceostatin I (2), and the known compound FR901464 (3) (Fig. 1), were isolated from the strain Pseudomonas sp. HS-NF-1408. In this paper, the details of fermentation, isolation, structure determination, and biological activity of two new derivatives are described.
The producing strain Pseudomonas sp. HS-NF-1408 was isolated from a soil sample collected from the Qingshan lake, located in Lin’an, Zhejiang province, China. The strain was identified as the genus Pseudomonas because its 16S rRNA sequence (accession no: MG386199 in the GenBank) showed a high similarity of 99% with that of the Pseudomonas chlororaphis strain XF10 (accession no: MF121986.1 in the GenBank) and it was deposited in the Pharmaceutical Research Culture Collection, Zhejiang Hisun Group Co. Ltd. with accession no: HS-NF-1408.Please provide the legend for Figure 1.Figure 1 Structures of compounds 1, 2 and 3
This strain was grown on an agar slant containing 30 g beef extract, 5 g peptone, and 15 g agar in 1.0 l of water, pH 7.0–7.2 and incubated for 6–7 days at 28 °C. The strain of stock culture was inoculated into 100 1.0 l Erlenmeyer flasks containing 36% volume of the seed medium at 30 °C for 24 h, shaken at 220 r.p.m. The seed medium consisted of polypeptone 1%, yeast extract 0.5%, and NaCl 0.5% in 1.0 l water, pH 7.0–7.2. All the media were sterilized at 121 °C for 20 min. Then, the entire culture was transferred into a 500 l fermentor containing 300 l of production medium consisting of defatted soybean meal 1%, corn steep liquor 0.5%, (NH4)2SO4 0.2%, soluble starch 1%, glycerin 1%, glucose 0.5%, MgSO4·7H2O 0.0006%, CaCO3 0.2%, adecanol LG-109 0.05%, and silicon KM-70 0.05% at pH 7.0–7.2. The fermentation was carried out at 28 °C for 6 days stirred at 220 r.p.m. with an aeration rate of 18,000 l of air per hour.
The final 300 l of broth from 500 l fermentor was filtered to separate mycelial cake and supernatant. The mycelial cake was extracted with MeOH (50 l) and the supernatant was subjected to a Diaion HP-20 resin (Mitsubushi Chemical, Tokyo, Japan) column eluting with 95% EtOH (50 l). The MeOH extract and the EtOH eluents were evaporated under reduced pressure to yield the crude extract. The crude extract was chromatographed on a silica gel (Qingdao Haiyang Chemical Group, Qingdao, China; 100–200 mesh) column and successively eluted with a stepwise gradient of CHCl3/MeOH (100:0-50:50, v-v) to give five fractions (Fr.1-Fr.5) based on the TLC profiles. Fr.2 was subjected to another silica gel column eluted with n-hexane/acetone (95:5-50:50, v:v) to give three fractions (Fr.2-1 to Fr.2-3). Fr.2-1 was further isolated by preparative HPLC (Shimadzu LC-8A, Shimadzu-C18, 5 μm, 250 × 20 mm2 inner diameter; 20 ml/min; 220/254 nm; Shimadzu, Kyoto, Japan) eluting with a stepwise gradient MeOH/H2O (50–100%, v/v, 40 min) to obtain five subfractions (Fr.2-1-1 to Fr.2-1-5) based on the retention times. Then, Fr.2-1-1 (tR 10.6 min) was purified by semi-preparative HPLC (Agilent 1100, Zorbax SB-C18, 5um, 9.4 × 250 mm2 inner diameter; 1.5 ml/min; 254 nm; Agilent, Palo Alto, CA, USA) eluting with CH3CN:H2O (50:50, v:v) to obtain spliceostatin H (1) (tR 8.4 min, 30 mg). Fr.2-1-2 (tR 12.1 min) was separated by semi-preparative HPLC eluting with CH3CN:H2O (40:60, v:v) to yield FR901464 (3) (tR 12.1 min, 63 mg). Fr.2-1-4 (tR 16.7 min) was isolated by semi-preparative HPLC eluting with CH3CN:H2O (50:50, v:v) to give spliceostatin I (2) (tR 16.9 min,6.3 mg). 1H and 13C NMR spectra were measured with a Bruker DRX-400 (400 MHz for 1H and 100 MHz for 13C) spectrometer (Bruker, Rheinstetten, Germany). The ESIMS and HRESIMS spectra were taken on a Q-TOF Micro LC–MS–MS mass spectrometer (Waters Co, Milford, MA, USA).
Compound 1 was isolated as colorless oil with [α]-60 (c 0.02, EtOH) and UV (EtOH) λmax nm (log ε): 236 (4.54). Its molecular formula was determined to be C27H43NO9 by HRESIMS at m/z 548.2825 [M + Na]+ (calcd as 548.2830 for C27H43NO9Na) and NMR data (Table 1). The IR spectrum showed absorption bands for hydroxyl (3369 cm−1) and carbonyl (1732 cm−1) functionalities. The 1H NMR spectrum of 1 (Table 1) displayed three doublet methyls at δH 1.04 (J = 7.3 Hz), 1.16 (J = 6.4 Hz) and 1.37 (J = 6.5 Hz), a singlet methyl at δH 1.39, an olefinic methyl at δH 1.81, an acetyl methyl at δH 2.04, seven methine proton signals from δH 3.30 to δH 4.39 and six downfield proton signals from δH 5.50 to δH 6.42. The 13C NMR spectrum (Table 1) exhibited 27 resonances ascribed to six methyls at δC 12.7, 14.9, 18.0, 20.3, 21.1, 29.1, four methylenes (one oxygenated) at δC 33.1, 36.9, 41.7, 66.8, seven sp 3 methines (five oxygenated) at δC 30.6, 48.6, 70.0, 71.7, 71.8, 76.7, 82.2, one hemiketal carbon at δC 97.8, one oxygen-bearing quaternary sp3 carbon at δC 74.8, five sp2 methines at δC 123.4, 126.3, 129.8, 138.7, 144.8, one sp2 quaternary carbon at δC 135.9 and two carbonyls at δC 167.5, 172.2. The 1H and 13C NMR data of 1 closely resembled those of NP69 except for the presence of a methylene carbon at δH 1.83, 1.90/δC 41.7 in 1 instead of the corresponding oxygenated methine (C-2) in NP6. The HMBC correlations (Fig. 2) from δH1.39 (H3-17) and δH 3.39, 3.57 (H2-18) to this carbon supported this assignment. Thus, the gross structure of 1 was established to be a 2-dehydroxy derivative of NP6, as shown in Fig. 1. The 1H–1H COSY correlations (Fig. 2) of H-4/H-5/H-6/H-7, H-9/H2-10/H-11/H-12/H2-13/H-14/H-15/H3-16, H-12/H3-20, H-2′/H-3′/H-4′/H3-5′ and the observed HMBC cross-peaks from H3-17 to C-1, from H2-18 to C-3 and C-4, from H3-19 to C-7, C-8, and C-9, from H3-2″ and H-4′ to C-1″ further confirmed the above structural assignment. In 1, the coupling constants of H-7 (δH6.40, d, J = 15.3 Hz) and H-2′ (δH6.01, d, J = 11.8 Hz) unambiguously revealed the double bond geometry at C-6 and C-2′ to be trans and cis, respectively. In the NOESY spectrum, the NOE correlations (Fig. 2) between H-7 and H-9 indicated the double bond at C-8 was trans. In addition, the relative configuration for H-4 and H-5 was anti based on the J value between H-4/H-5 (9.2 Hz). The relative stereochemistry of 1 was assigned to be the same as that of FR901464 [8]. The NOE cross peaks from H2-10 to H3-20 and from H-4 to H2-18 further supported the assignment. From this finding, the structure of 1 was established and named as spliceostatin H. All NMR spectra data of compound 1 are present in Supplementary file (Figure S1–S10).
Compound 2 was isolated as colorless oil with[α]-50 (c 0.02, EtOH) and UV (EtOH) λmax nm (log ε): 235 (4.42). Its molecular formula was established as C30H47NO9 by HRESIMS at m/z 566.3320 [M + H]+ (calcd as 566.3324 forC30H48NO9) and NMR data (Table 1), requiring 8° of unsaturation. The IR absorption bands at 3431 cm−1, 1724 cm−1 were characteristics of hydroxyl and carbonyl groups. The 1H NMR data (Table 1) of 2 displayed three doublet methyls (δH 1.02, 1.14, 1.34), one triplet methyl (δH 1.19), an olefinic methyl (δH 1.75) and an acetyl methyl (δH 2.01). The 13C NMR data (Table 1) showed resonances for 30 carbons, which included six methyls, three double bonds, seven sp3 methylenes (including two oxygenated at δC 68.0 and 79.7), seven sp3 methines (five oxygenated), three carbonyls and one oxygen-bearing quaternary carbon (δC 76.0). Comparision of the NMR spectroscopic data and analyses of the 2D NMR spectra revealed the gross structure of 2 to be closely related to NP7 [9] except for the absence of an acetyl group and the presence of one ethyl group (δH/δC 1.19/15.4, and 3.50/68.0) in 2. The ethyl group was connected with the C-18 methylene via an oxygen atom, as evident from the methylene protons (δH 3.50) of the ethyl moiety exhibiting HMBC correlations (Fig. 3) to C-18 (δC 79.7). The large coupling constant of H-7 (δH 6.29, J = 15.8 Hz) and the NOE correlation (Fig. 3) between H3-19 and H2-10 indicated that the geometry of the two double bond at C-6 and C-8 were all trans. The coupling constant of H-2′ (δH 5.98, d, J = 11.8 Hz) revealed the double bond at C-2′ was cis. The cross peaks between H-5 and H2-17 in NOESY spectrum suggested a 1, 3-diaxial relationship. On the basis of biogenetic considerations, the stereochemistry of other chiral centers was assigned as that of 1 according to the NOE correlations from H2-18 to H-4, from H3-20 to H2-10 and the concurrence with 1. Therefore, the structure of 2 was established and named as spliceostatin I. The O-ethyl group suggested that this compound may be an artifact. So, it was analyzed by HPLC together with the methanol extract of the fermentation broth. The absence of 2 in the extract suggested the ethoxy group was elaborated in the course of the extraction or purification process. All NMR spectra data of compound 2 are present in Supplementary file (Figure S11–S20).
Compound 3 was identified as FR901464 by comparing the NMR spectral data with those reported in literature [8].
The cytotoxicity of compounds 1, 2 and 3 were assayed for growth-inhibition activity in vitro against two human tumor cell lines, human hepatocellular liver carcinoma cells HepG2 and human lung tumor cells A549 according to the CCK8 colorimetric method as reported in our previous papers [10, 11] using doxorubicin as positive control (Table 2). As a result, compound 1 exhibited cytotoxic activity against the two tumor cell lines and compound 2 only exhibited potent cytotoxic activity against A549 cell lines.
References
He HY, et al. Cytotoxic spliceostatins from Burkholderia sp. and their semisynthetic analogues. J Nat Prod. 2014;77:1864–70.
Motoyoshi H, et al. Structure-activity relationship for FR901464: aversatile method for the conversion and preparation of biologically active biotinylated probes. Biosci Biotechnol Biochem. 2004;68:2178–82.
Eustaquio AS, et al. Spliceostatin hemiketal biosynthesis in Bukhholderia spp. iscatalyzed by an iron/α-ketoglutarate-dependent dioxygenase. Proc Natl Acad Sci USA. 2014;111:3376–85.
Albert BJ, et al. Total synthesis, fragmentation studies, and antitumor/antiproliferative activities of FR901464 and its low picomolar analogue. J Am Chem Soc. 2007;129:2648–59.
Liu XY, et al. Isolation and characterization of spiliceostatin B, a new analogue of FR901464, from Pseudomonas sp. J Antibiot. 2013;66:555–8.
Osman S, et al. Structure requirement for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464. Chem Eur J. 2011;17:895–904.
Eustaquio AS, et al. Biosythetic engineering and fermentation media development leads to gram-scale production of spliceostatin natural products in Burkholderia sp. Metab Eng. 2016;33:67–75.
Nakajima H, et al. New antitumor substances, FR901463, FR901464 and FR901465. III. Structures of FR901463, FR901464 and FR901465. J Antibiot. 1997;50:96–99.
Dirico, JK. Spliceostantin analogs. WO 2014/068443 A1 (2014).
Wang JD, et al. HS071, a new furan-type cytotoxic metabolite from Streptomyces sp. HS-HY-071. J Antibiot. 2008;61:623–6.
Wang JD, et al. Five new epothilone metabolites from Sorangium cellulosum strain So0157-2. J Antibiot. 2009;62:483–7.
Acknowledgements
This work was supported in part by grants from the National Natural Youth Science Foundation of China (No. 31701858), Youth innovation talent program for general undergraduate colleges of Heilongjiang Province (UNPYSCT-2017017), the Heilongjiang Postdoctoral Fund (LBH-Z17015) and the ‘Young Talents’ Project of Northeast Agricultural University (17QC14).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Zhao, Y., Zhao, J., Lu, C. et al. Two new spliceostatin analogs from the strain Pseudomonas sp. HS-NF-1408. J Antibiot 71, 667–671 (2018). https://doi.org/10.1038/s41429-018-0052-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41429-018-0052-0